BVA Companion by Daxor
By Daxor
BVA Companion by Daxor is a clinical reference and diagnostic data tool for healthcare providers using Blood Volume Analysis hardware on iOS.
The App DNA
What makes this app unique?
The app removes the friction of accessing diagnostic phenotype data and reference materials during the patient care pathway, ensuring clinicians can utilize BVA hardware effectively.
For Licensed clinicians and healthcare providers who utilize Blood Volume Analysis in their medical practice.
What does it look like?
Key features
Provides clinical reference tools for practitioners utilizing BVA within patient care pathways.
Displays patient phenotype data and analysis results within the mobile interface.
Access to reference materials and documentation for BVA procedures.
How much does it cost?
The app is a free utility provided by the manufacturer to support the use of their diagnostic hardware.
Velocity
Maintenance developmentperformanceShow more...
The app has been inactive for approximately 5.6 months, with the latest release occurring 170 days ago. Development is currently limited to minor stability and bug-fix updates, with no evidence of new features or live-service content. The cadence is consistent with a maintenance-only lifecycle, as no significant updates have been deployed to the store in the observed window.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for BVA Companion by Daxor
How's the Medical market?
BVA Companion by Daxor maintains a 5.0-star rating across its limited user base, functioning as a niche B2B utility rather than a consumer-facing tool.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for BVA Companion by Daxor
Where is it heading?
BVA Companion by Daxor is positioned as a static support tool for a proprietary hardware ecosystem. Future clinical adoption depends on the hardware's market reach rather than mobile feature velocity, so the current maintenance posture is likely sufficient for the intended B2B use case.
- The app remains in a maintenance cycle with no new features, signaling a focus on stability over expansion for the BVA platform.
The SWOT
- Centralized clinical documentation reduces training overhead for new staff using the BVA system.
- Integration of automated alerts for phenotype results could increase the utility of the BVA hardware for medical providers.
Next best moves
Audit clinical workflow needs because the app has been in maintenance for 170 days → identify high-impact feature gaps
The counter-intuitive read
The app's maintenance-mode status is a strategic choice…
Read the full takeBottom line
Maintaining the current reference library ensures baseline support for existing BVA hardware users, but the lack of feature expansion limits the app's ability to drive deeper clinical adoption.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated